An interventional study of Postural change from supine to sitting and Mobilization to a chair in Anemia, sponsored by Deventer Ziekenhuis. Not yet recruiting at 1 site in Netherlands. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-06-03.
Sponsored by Deventer Ziekenhuis · Not applicable, Interventional, and Diagnostic
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 47 studies in Anemia with a site in Netherlands — 5 open to participants now, 10 under way, 7 of them phase 3. Anemia · Netherlands.
Among the 47 studies in Anemia with a site in Netherlands, this one is the 33rd largest by planned enrollment of the 38 interventional ones that give a count, is one of 3 that started in 2024, is one of 5 with no phase, and was the 43rd registered.
1,812 studies on the registry are indexed under Anemia; 212 are open to participants now.
Browse Anemia studies →5 of the 47 studies in Anemia with a site in Netherlands are open now. Recruiting first, the newest first:
Takeda · Sites in Netherlands, United States, Argentina and 25 more countries
Ages 18+
CSL Behring · Sites in Netherlands, United States, Belgium and 4 more countries
Ages 18+
Novartis Pharmaceuticals · Sites in Netherlands, United States, Brazil and 3 more countries
Ages 2–18
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · Sites in Netherlands, Austria, Belgium and 1 more country
Ages 18+
A study can be open while its sites in Netherlands have not opened yet or have stopped. Only those recruiting at a site in Netherlands →
Of the 117 Anemia studies recruiting now, 66 (56%) set no upper age limit and 33 (28%) stop at 75 or younger; 32 take children under 18; 21 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
47 studies; the count open now beside each. This study's row is marked.
First in 1998; this study’s year is marked. 3 started in 2024.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 24 is below the median of 117 across 1,338 interventional studies indexed under Anemia.
Median enrollment 219 across the 38 interventional studies, 488 across the 9 observational. Of the 33 that completed or were terminated, 19 (58%) have results posted.
This tab as a report to print or save as PDF → With an account.
34 of 47 have an industry lead sponsor. The 10 most frequent:
Deventer Ziekenhuis is the lead sponsor of 5 studies on the registry; 4 are open to participants now.
Deventer Ziekenhuis has 1 study filed under Anemia — fewer than ten, so there is no comparison to draw.
3 of the studies in Anemia with a site in Netherlands that are under way reach primary completion within a year, 2 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT04747613Phase 3Novartis PharmaceuticalsLong-term Safety and Tolerability of Iptacopan in Patients With Paroxysmal Nocturnal Hemoglobinuria | 2027-10-18 |
| NCT05970172Phase 3Astellas Pharma Global Development, Inc.A Study of Roxadustat to Treat Anemia in Children and Teenagers With Chronic Kidney Disease | 2027-10-30 |
| NCT06560164Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)Restrictive Versus Liberal Thresholds for RBC Transfusion in ECMO | 2027-10-01 |
Add all 3 to your calendar (.ics) → With an account.
Among the 47 studies in Anemia with a site in Netherlands, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Monitoring hemoglobin levels (Hb) is important to identify anemia in hospitalized patients. Changes in posture and mobilization efforts, as demonstrated by previous research, can lead to significant shifts in Hb concentrations. This phenomenon has not been studied in ICU patients.
This study aims to investigate whether postural changes and mobilisation affect Hb in ICU patients. We hypothesize that significant Hb shifts may occur, potentially leading to misinterpretations of anemia and unnecessary diagnostic and therapeutic workup. Understanding this impact can guide clinical practice and prevent unwarranted interventions.
Rationale:
Monitoring hemoglobin levels (Hb) is important to identify anemia in hospitalized patients. Changes in posture and mobilization efforts, as demonstrated by previous research, can lead to significant shifts in Hb concentrations. Low Hb levels due to these shifts are termed 'postural pseudoanemia'.
This phenomenon has not been studied in ICU patients. Many factors may affect Hb concentrations in ICU patients, including plasma volume shifts, bleeding, repeated phlebotomies, hemolysis, bone marrow suppression and functional iron deficiency. When this leads to significant anemia, patients may be treated with red blood cell transfusions. However, blood transfusions have been associated with adverse reactions and should only be performed for appropriate indications. If postural pseudoanemia occurs in ICU patients this could lead to patient harm through inadvertent investigations and red blood cell transfusions. The occurrence of postural pseudoanemia in ICU patients may differ from previous studies because ICU patients are more frequently immobilized for more prolonged periods.
This study aims to investigate whether postural changes affect Hb in ICU patients. We hypothesize that significant Hb shifts may occur, potentially leading to misinterpretations of anemia and unnecessary diagnostic and therapeutic workup. Understanding this impact can guide clinical practice and prevent unwarranted interventions.
Objective:
Main objective: To assess Hb levels in ICU patients upon a change in posture from supine to upright and following mobilization to a chair.
Secondary objectives:
To seek correlations between hemoglobin shifts and changes in serum albumin concentrations upon a change in posture from supine to sitting and following mobilization to a chair.
To seek correlations between hemoglobin shifts and changes in serum uric acid concentrations upon a change in posture from supine to sitting and following mobilization to a chair.
To seek correlations between hemoglobin shifts and levels of CRP and ESR upon a change in posture from supine to sitting and following mobilization to a chair.
To compare hemoglobin concentrations following > 6 hours in supine position at 24 hours with pre-intervention levels for patients remaining in the ICU.
Any other changes seen in the lab measurements or vital parameters upon a change in posture?
Study design:
Prospective uncontrolled interventional study.
Study population:
Patients > 18 years old, admitted to the intensive care unit.
Intervention:
All patients will undergo a change in posture from supine to upright, followed by mobilization to a chair.
Main study parameters/endpoints:
Relative percentage change in Hb.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.
Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Cancer (malignancy)
Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.
Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Hemoglobin concentration after sitting in bed (passively) for \>30 min, and after mobilization to a chair for \>30 min
Procedure: Postural change from supine to sitting · Procedure: Mobilization to a chair
Patients go from supine to sitting position in bed (passive)
Patients go from the bed to sitting in a chair (active)
Hemoglobin
Hemoglobin concentration
Time frame: 3 hours
Albumin
Albumin concentration
Time frame: 3 hours
Uric acid
Uric acid concentration
Time frame: 3 hours
Plan to share: Yes — Data can be obtained from the principal investigator upon request.
Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Clinical study report, Analytic code
Time frame: After preparation of the manuscript.
Access criteria: A written request must be sent to the principal investigator.
No publications or documents are linked to this record.
Start is estimated for Jun 2024; primary completion for Oct 2024, 4 months later.
Of 165 non-industry interventional studies with no phase under Anemia, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 30. This study's planned 4 months is below that.
Counting every sponsor, half of 179 studies reached it within 17 months; a quarter within 7 and three quarters within 28.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in May 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Deventer Ziekenhuis